APO Research
Talk to an analyst

APO RESEARCH · REPORT

General Anesthetic for Surgery

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global General Anesthetic for Surgery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025196 pages

Choose your research edition.

Industry ResearchGeneral Anesthetic for Surgery Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal General Anesthetic for Surgery Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal General Anesthetic for Surgery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal General Anesthetic for Surgery Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal General Anesthetic for Surgery Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global General Anesthetic for Surgery market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for General Anesthetic for Surgery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for General Anesthetic for Surgery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for General Anesthetic for Surgery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for General Anesthetic for Surgery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of General Anesthetic for Surgery include Yichang Humanwell, Xi'an Libang, Nhwa, Hengrui, Fresenius-Kabi, B.Braun, Baxter Healthcare, AbbVie and Piramal, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global General Anesthetic for Surgery market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of General Anesthetic for Surgery and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents General Anesthetic for Surgery sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the General Anesthetic for Surgery market size, projected growth trends, production technologies, key applications, and end-use industries.

General Anesthetic for Surgery Segment by Company

Yichang Humanwell

Xi'an Libang

Nhwa

Hengrui

Fresenius-Kabi

B.Braun

Baxter Healthcare

AbbVie

Piramal

Maruishi

Hikma Pharmaceuticals

Aspen Pharma

General Anesthetic for Surgery Segment by Type

Isoflurane

Etomidate

Remifentanil

Sevoflurane

Propofol

Other

General Anesthetic for Surgery Segment by Application

Intravenous Anesthetics

Inhalational Anesthetics

General Anesthetic for Surgery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global General Anesthetic for Surgery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of General Anesthetic for Surgery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of General Anesthetic for Surgery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the General Anesthetic for Surgery market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of General Anesthetic for Surgery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of General Anesthetic for Surgery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of General Anesthetic for Surgery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. General Anesthetic for Surgery Industry Trends Table 2. General Anesthetic for Surgery Industry Drivers Table 3. General Anesthetic for Surgery Industry Opportunities and Challenges Table 4. General Anesthetic for Surgery Industry Restraints Table 5. Global General Anesthetic for Surgery Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global General Anesthetic for Surgery Revenue Market Share by Manufacturers (2021-2026) Table 7. Global General Anesthetic for Surgery Sales by Manufacturers (k units) & (2021-2026) Table 8. Global General Anesthetic for Surgery Sales Market Share by Manufacturers Table 9. Global General Anesthetic for Surgery Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global General Anesthetic for Surgery Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global General Anesthetic for Surgery Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global General Anesthetic for Surgery Manufacturers, Product Type & Application Table 13. Global General Anesthetic for Surgery Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global General Anesthetic for Surgery by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Isoflurane Table 17. Major Manufacturers of Etomidate Table 18. Major Manufacturers of Remifentanil Table 19. Major Manufacturers of Sevoflurane Table 20. Major Manufacturers of Propofol Table 21. Major Manufacturers of Other Table 22. Global General Anesthetic for Surgery Sales by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global General Anesthetic for Surgery Sales by Type (2021-2026) & (k units) Table 24. Global General Anesthetic for Surgery Sales by Type (2027-2032) & (k units) Table 25. Global General Anesthetic for Surgery Sales Market Share by Type (2021-2026) Table 26. Global General Anesthetic for Surgery Sales Market Share by Type (2027-2032) Table 27. Global General Anesthetic for Surgery Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 28. Global General Anesthetic for Surgery Revenue by Type (2021-2026) & (k units) Table 29. Global General Anesthetic for Surgery Revenue by Type (2027-2032) & (k units) Table 30. Global General Anesthetic for Surgery Revenue Market Share by Type (2021-2026) Table 31. Global General Anesthetic for Surgery Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Intravenous Anesthetics Table 33. Major Manufacturers of Inhalational Anesthetics Table 34. Global General Anesthetic for Surgery Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global General Anesthetic for Surgery Sales by Application (2021-2026) & (k units) Table 36. Global General Anesthetic for Surgery Sales by Application (2027-2032) & (k units) Table 37. Global General Anesthetic for Surgery Sales Market Share by Application (2021-2026) Table 38. Global General Anesthetic for Surgery Sales Market Share by Application (2027-2032) Table 39. Global General Anesthetic for Surgery Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global General Anesthetic for Surgery Revenue by Application (2021-2026) & (k units) Table 41. Global General Anesthetic for Surgery Revenue by Application (2027-2032) & (k units) Table 42. Global General Anesthetic for Surgery Revenue Market Share by Application (2021-2026) Table 43. Global General Anesthetic for Surgery Revenue Market Share by Application (2027-2032) Table 44. Global General Anesthetic for Surgery Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global General Anesthetic for Surgery Sales by Region (2021-2026) & (k units) Table 46. Global General Anesthetic for Surgery Sales Market Share by Region (2021-2026) Table 47. Global General Anesthetic for Surgery Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global General Anesthetic for Surgery Sales Forecasted Market Share by Region (2027-2032) Table 49. North America General Anesthetic for Surgery Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America General Anesthetic for Surgery Sales by Country (2021-2026) & (k units) Table 51. North America General Anesthetic for Surgery Sales by Country (2027-2032) & (k units) Table 52. Europe General Anesthetic for Surgery Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe General Anesthetic for Surgery Sales by Country (2021-2026) & (k units) Table 54. Europe General Anesthetic for Surgery Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific General Anesthetic for Surgery Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific General Anesthetic for Surgery Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific General Anesthetic for Surgery Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa General Anesthetic for Surgery Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa General Anesthetic for Surgery Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa General Anesthetic for Surgery Sales by Country (2027-2032) & (k units) Table 61. Global General Anesthetic for Surgery Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global General Anesthetic for Surgery Revenue by Region (2021-2026) & (US$ Million) Table 63. Global General Anesthetic for Surgery Revenue by Region (2027-2032) & (US$ Million) Table 64. Global General Anesthetic for Surgery Revenue Market Share by Region (2021-2026) Table 65. Global General Anesthetic for Surgery Revenue Market Share by Region (2027-2032) Table 66. Yichang Humanwell Company Information Table 67. Yichang Humanwell Business Overview Table 68. Yichang Humanwell General Anesthetic for Surgery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Yichang Humanwell General Anesthetic for Surgery Product Portfolio Table 70. Yichang Humanwell Recent Development Table 71. Xi'an Libang Company Information Table 72. Xi'an Libang Business Overview Table 73. Xi'an Libang General Anesthetic for Surgery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Xi'an Libang General Anesthetic for Surgery Product Portfolio Table 75. Xi'an Libang Recent Development Table 76. Nhwa Company Information Table 77. Nhwa Business Overview Table 78. Nhwa General Anesthetic for Surgery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Nhwa General Anesthetic for Surgery Product Portfolio Table 80. Nhwa Recent Development Table 81. Hengrui Company Information Table 82. Hengrui Business Overview Table 83. Hengrui General Anesthetic for Surgery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Hengrui General Anesthetic for Surgery Product Portfolio Table 85. Hengrui Recent Development Table 86. Fresenius-Kabi Company Information Table 87. Fresenius-Kabi Business Overview Table 88. Fresenius-Kabi General Anesthetic for Surgery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Fresenius-Kabi General Anesthetic for Surgery Product Portfolio Table 90. Fresenius-Kabi Recent Development Table 91. B.Braun Company Information Table 92. B.Braun Business Overview Table 93. B.Braun General Anesthetic for Surgery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. B.Braun General Anesthetic for Surgery Product Portfolio Table 95. B.Braun Recent Development Table 96. Baxter Healthcare Company Information Table 97. Baxter Healthcare Business Overview Table 98. Baxter Healthcare General Anesthetic for Surgery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Baxter Healthcare General Anesthetic for Surgery Product Portfolio Table 100. Baxter Healthcare Recent Development Table 101. AbbVie Company Information Table 102. AbbVie Business Overview Table 103. AbbVie General Anesthetic for Surgery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. AbbVie General Anesthetic for Surgery Product Portfolio Table 105. AbbVie Recent Development Table 106. Piramal Company Information Table 107. Piramal Business Overview Table 108. Piramal General Anesthetic for Surgery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Piramal General Anesthetic for Surgery Product Portfolio Table 110. Piramal Recent Development Table 111. Maruishi Company Information Table 112. Maruishi Business Overview Table 113. Maruishi General Anesthetic for Surgery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Maruishi General Anesthetic for Surgery Product Portfolio Table 115. Maruishi Recent Development Table 116. Hikma Pharmaceuticals Company Information Table 117. Hikma Pharmaceuticals Business Overview Table 118. Hikma Pharmaceuticals General Anesthetic for Surgery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Hikma Pharmaceuticals General Anesthetic for Surgery Product Portfolio Table 120. Hikma Pharmaceuticals Recent Development Table 121. Aspen Pharma Company Information Table 122. Aspen Pharma Business Overview Table 123. Aspen Pharma General Anesthetic for Surgery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Aspen Pharma General Anesthetic for Surgery Product Portfolio Table 125. Aspen Pharma Recent Development Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. General Anesthetic for Surgery Distributors List Table 129. General Anesthetic for Surgery Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. General Anesthetic for Surgery Product Image Figure 2. Global General Anesthetic for Surgery Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global General Anesthetic for Surgery Market Size (2021-2032) & (US$ Million) Figure 4. Global General Anesthetic for Surgery Sales (2021-2032) & (k units) Figure 5. Global General Anesthetic for Surgery Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 General Anesthetic for Surgery Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Isoflurane Image Figure 9. Etomidate Image Figure 10. Remifentanil Image Figure 11. Sevoflurane Image Figure 12. Propofol Image Figure 13. Other Image Figure 14. Global General Anesthetic for Surgery Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global General Anesthetic for Surgery Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global General Anesthetic for Surgery Sales Market Share by Type (2021-2032) Figure 17. Global General Anesthetic for Surgery Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global General Anesthetic for Surgery Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global General Anesthetic for Surgery Revenue Market Share by Type (2021-2032) Figure 20. Intravenous Anesthetics Image Figure 21. Inhalational Anesthetics Image Figure 22. Global General Anesthetic for Surgery Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global General Anesthetic for Surgery Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global General Anesthetic for Surgery Sales Market Share by Application (2021-2032) Figure 25. Global General Anesthetic for Surgery Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global General Anesthetic for Surgery Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global General Anesthetic for Surgery Revenue Market Share by Application (2021-2032) Figure 28. North America General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America General Anesthetic for Surgery Sales Market Share by Country (2021-2032) Figure 30. U.S. General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe General Anesthetic for Surgery Sales Market Share by Country (2021-2032) Figure 35. Germany General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 36. France General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific General Anesthetic for Surgery Sales Market Share by Country (2021-2032) Figure 42. China General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 46. India General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa General Anesthetic for Surgery Sales Market Share by Country (2021-2032) Figure 50. Brazil General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile General Anesthetic for Surgery Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global General Anesthetic for Surgery Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global General Anesthetic for Surgery Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America General Anesthetic for Surgery Revenue (2021-2032) & (US$ Million) Figure 61. North America General Anesthetic for Surgery Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe General Anesthetic for Surgery Revenue (2021-2032) & (US$ Million) Figure 63. Europe General Anesthetic for Surgery Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific General Anesthetic for Surgery Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific General Anesthetic for Surgery Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa General Anesthetic for Surgery Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa General Anesthetic for Surgery Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. General Anesthetic for Surgery Value Chain Figure 69. Manufacturing Cost Structure Figure 70. General Anesthetic for Surgery Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Isoflurane
  • Etomidate
  • Remifentanil
  • Sevoflurane
  • Propofol
  • Other
Applications
  • Intravenous Anesthetics
  • Inhalational Anesthetics
Companies covered
  • Yichang Humanwell
  • Xi'an Libang
  • Nhwa
  • Hengrui
  • Fresenius-Kabi
  • B.Braun
  • Baxter Healthcare
  • AbbVie
  • Piramal
  • Maruishi
  • Hikma Pharmaceuticals
  • Aspen Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global General Anesthetic for Surgery Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global General Anesthetic for Surgery Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global General Anesthetic for Surgery Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global General Anesthetic for Surgery Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global General Anesthetic for Surgery Market Dynamics
  1. 2.1 General Anesthetic for Surgery Industry Trends
  2. 2.2 General Anesthetic for Surgery Industry Drivers
  3. 2.3 General Anesthetic for Surgery Industry Opportunities and Challenges
  4. 2.4 General Anesthetic for Surgery Industry Restraints
3 General Anesthetic for Surgery Market by Manufacturers
  1. 3.1 Global General Anesthetic for Surgery Revenue by Manufacturers (2021-2026)
  2. 3.2 Global General Anesthetic for Surgery Sales by Manufacturers (2021-2026)
  3. 3.3 Global General Anesthetic for Surgery Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global General Anesthetic for Surgery Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global General Anesthetic for Surgery Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global General Anesthetic for Surgery Manufacturers, Product Type & Application
  7. 3.7 Global General Anesthetic for Surgery Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global General Anesthetic for Surgery Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 General Anesthetic for Surgery Players Market Share by Revenue in 2025
  11. 3.8.3 2025 General Anesthetic for Surgery Tier 1, Tier 2, and Tier 3
4 General Anesthetic for Surgery Market by Type
  1. 4.1 General Anesthetic for Surgery Type Introduction
  2. 4.1.1 Isoflurane
  3. 4.1.2 Etomidate
  4. 4.1.3 Remifentanil
  5. 4.1.4 Sevoflurane
  6. 4.1.5 Propofol
  7. 4.1.6 Other
  8. 4.2 Global General Anesthetic for Surgery Sales by Type
  9. 4.2.1 Global General Anesthetic for Surgery Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global General Anesthetic for Surgery Sales by Type (2021-2032)
  11. 4.2.3 Global General Anesthetic for Surgery Sales Market Share by Type (2021-2032)
  12. 4.3 Global General Anesthetic for Surgery Revenue by Type
  13. 4.3.1 Global General Anesthetic for Surgery Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global General Anesthetic for Surgery Revenue by Type (2021-2032)
  15. 4.3.3 Global General Anesthetic for Surgery Revenue Market Share by Type (2021-2032)
5 General Anesthetic for Surgery Market by Application
  1. 5.1 General Anesthetic for Surgery Application Introduction
  2. 5.1.1 Intravenous Anesthetics
  3. 5.1.2 Inhalational Anesthetics
  4. 5.2 Global General Anesthetic for Surgery Sales by Application
  5. 5.2.1 Global General Anesthetic for Surgery Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global General Anesthetic for Surgery Sales by Application (2021-2032)
  7. 5.2.3 Global General Anesthetic for Surgery Sales Market Share by Application (2021-2032)
  8. 5.3 Global General Anesthetic for Surgery Revenue by Application
  9. 5.3.1 Global General Anesthetic for Surgery Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global General Anesthetic for Surgery Revenue by Application (2021-2032)
  11. 5.3.3 Global General Anesthetic for Surgery Revenue Market Share by Application (2021-2032)
6 Global General Anesthetic for Surgery Sales by Region
  1. 6.1 Global General Anesthetic for Surgery Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global General Anesthetic for Surgery Sales by Region (2021-2032)
  3. 6.2.1 Global General Anesthetic for Surgery Sales by Region (2021-2026)
  4. 6.2.2 Global General Anesthetic for Surgery Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America General Anesthetic for Surgery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America General Anesthetic for Surgery Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe General Anesthetic for Surgery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe General Anesthetic for Surgery Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific General Anesthetic for Surgery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific General Anesthetic for Surgery Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa General Anesthetic for Surgery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa General Anesthetic for Surgery Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global General Anesthetic for Surgery Revenue by Region
  1. 7.1 Global General Anesthetic for Surgery Revenue by Region
  2. 7.1.1 Global General Anesthetic for Surgery Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global General Anesthetic for Surgery Revenue by Region (2021-2026)
  4. 7.1.3 Global General Anesthetic for Surgery Revenue by Region (2027-2032)
  5. 7.1.4 Global General Anesthetic for Surgery Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America General Anesthetic for Surgery Revenue (2021-2032)
  8. 7.2.2 North America General Anesthetic for Surgery Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe General Anesthetic for Surgery Revenue (2021-2032)
  11. 7.3.2 Europe General Anesthetic for Surgery Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific General Anesthetic for Surgery Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific General Anesthetic for Surgery Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa General Anesthetic for Surgery Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa General Anesthetic for Surgery Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yichang Humanwell
  2. 8.1.1 Yichang Humanwell Company Information
  3. 8.1.2 Yichang Humanwell Business Overview
  4. 8.1.3 Yichang Humanwell General Anesthetic for Surgery Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yichang Humanwell General Anesthetic for Surgery Product Portfolio
  6. 8.1.5 Yichang Humanwell Recent Developments
  7. 8.2 Xi'an Libang
  8. 8.2.1 Xi'an Libang Company Information
  9. 8.2.2 Xi'an Libang Business Overview
  10. 8.2.3 Xi'an Libang General Anesthetic for Surgery Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Xi'an Libang General Anesthetic for Surgery Product Portfolio
  12. 8.2.5 Xi'an Libang Recent Developments
  13. 8.3 Nhwa
  14. 8.3.1 Nhwa Company Information
  15. 8.3.2 Nhwa Business Overview
  16. 8.3.3 Nhwa General Anesthetic for Surgery Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nhwa General Anesthetic for Surgery Product Portfolio
  18. 8.3.5 Nhwa Recent Developments
  19. 8.4 Hengrui
  20. 8.4.1 Hengrui Company Information
  21. 8.4.2 Hengrui Business Overview
  22. 8.4.3 Hengrui General Anesthetic for Surgery Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hengrui General Anesthetic for Surgery Product Portfolio
  24. 8.4.5 Hengrui Recent Developments
  25. 8.5 Fresenius-Kabi
  26. 8.5.1 Fresenius-Kabi Company Information
  27. 8.5.2 Fresenius-Kabi Business Overview
  28. 8.5.3 Fresenius-Kabi General Anesthetic for Surgery Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Fresenius-Kabi General Anesthetic for Surgery Product Portfolio
  30. 8.5.5 Fresenius-Kabi Recent Developments
  31. 8.6 B.Braun
  32. 8.6.1 B.Braun Company Information
  33. 8.6.2 B.Braun Business Overview
  34. 8.6.3 B.Braun General Anesthetic for Surgery Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 B.Braun General Anesthetic for Surgery Product Portfolio
  36. 8.6.5 B.Braun Recent Developments
  37. 8.7 Baxter Healthcare
  38. 8.7.1 Baxter Healthcare Company Information
  39. 8.7.2 Baxter Healthcare Business Overview
  40. 8.7.3 Baxter Healthcare General Anesthetic for Surgery Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Baxter Healthcare General Anesthetic for Surgery Product Portfolio
  42. 8.7.5 Baxter Healthcare Recent Developments
  43. 8.8 AbbVie
  44. 8.8.1 AbbVie Company Information
  45. 8.8.2 AbbVie Business Overview
  46. 8.8.3 AbbVie General Anesthetic for Surgery Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AbbVie General Anesthetic for Surgery Product Portfolio
  48. 8.8.5 AbbVie Recent Developments
  49. 8.9 Piramal
  50. 8.9.1 Piramal Company Information
  51. 8.9.2 Piramal Business Overview
  52. 8.9.3 Piramal General Anesthetic for Surgery Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Piramal General Anesthetic for Surgery Product Portfolio
  54. 8.9.5 Piramal Recent Developments
  55. 8.10 Maruishi
  56. 8.10.1 Maruishi Company Information
  57. 8.10.2 Maruishi Business Overview
  58. 8.10.3 Maruishi General Anesthetic for Surgery Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Maruishi General Anesthetic for Surgery Product Portfolio
  60. 8.10.5 Maruishi Recent Developments
  61. 8.11 Hikma Pharmaceuticals
  62. 8.11.1 Hikma Pharmaceuticals Company Information
  63. 8.11.2 Hikma Pharmaceuticals Business Overview
  64. 8.11.3 Hikma Pharmaceuticals General Anesthetic for Surgery Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hikma Pharmaceuticals General Anesthetic for Surgery Product Portfolio
  66. 8.11.5 Hikma Pharmaceuticals Recent Developments
  67. 8.12 Aspen Pharma
  68. 8.12.1 Aspen Pharma Company Information
  69. 8.12.2 Aspen Pharma Business Overview
  70. 8.12.3 Aspen Pharma General Anesthetic for Surgery Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Aspen Pharma General Anesthetic for Surgery Product Portfolio
  72. 8.12.5 Aspen Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 General Anesthetic for Surgery Value Chain Analysis
  2. 9.1.1 General Anesthetic for Surgery Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 General Anesthetic for Surgery Production Mode & Process
  6. 9.2 General Anesthetic for Surgery Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 General Anesthetic for Surgery Distributors
  9. 9.2.3 General Anesthetic for Surgery Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst